bluebird bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good morning. I'm Salveen Richter, Biotechnology Analyst at Goldman Sachs, and we're pleased to have bluebird bio with us. From the company, we have Chip Baird, Chief Financial Officer; Philip Gregory, Chief Scientific Officer; and Joanne Smith-Farrell, Chief Business Officer and Head of Oncology.
Questions & Answers
And with that, to kick it off, maybe we could start with kind of a big picture question here. Given that you're in fields here, both on the rare disease side, then on the oncology side with genomic medicine, that face a relatively steep curve of innovation and optimization, as you look at portfolio management, how do you position your drug and technology portfolio to stay at the forefront as you look forward?
Salveen, so I'll start there and ask Philip and Joanne to comment as well. But wanted to maybe
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
